| 3413 |
1924: Increased,Cardiac fibrosis |
1535: Heart failure |
Nov 21, 2024 |
Nov 21, 2024 |
1 AOP
|
| 2982 |
1928: increased,Vascular endothelial dysfunction |
2160: Angiogenesis disfunction |
Aug 19, 2023 |
Aug 19, 2023 |
None
|
| 3019 |
1928: increased,Vascular endothelial dysfunction |
2179: Impaired Platelet Aggregation |
Aug 21, 2023 |
Aug 21, 2023 |
1 AOP
|
| 3027 |
1928: increased,Vascular endothelial dysfunction |
2178: Vascular barrier disruption |
Aug 21, 2023 |
Aug 21, 2023 |
1 AOP
|
| 3031 |
1928: increased,Vascular endothelial dysfunction |
2181: Angiogenesis dysfunction |
Aug 28, 2023 |
Aug 28, 2023 |
5 AOPs
|
| 3297 |
1928: increased,Vascular endothelial dysfunction |
2161: Increase, Vascular disrupting effects |
Jul 9, 2024 |
Jul 9, 2024 |
1 AOP
|
| 1622 |
1455: Sustained inflammatory cytokine release |
1032: Increased, secretion of local growth factors |
Jul 26, 2017 |
Jul 26, 2017 |
None
|
| 1633 |
1455: Sustained inflammatory cytokine release |
1456: Differentiation of fibroblasts |
Jul 26, 2017 |
Jul 26, 2017 |
None
|
| 2065 |
1740: ACE2 enzymatic inhibition |
1752: Increased AngII |
Mar 17, 2020 |
Mar 17, 2020 |
1 AOP
|
| 2321 |
1740: ACE2 enzymatic inhibition |
1741: Induced, Angiotensin (Ang) II accumulation |
Apr 10, 2021 |
Apr 10, 2021 |
None
|
| 2434 |
1740: ACE2 enzymatic inhibition |
1743: Increase plasma Ang II |
Jul 13, 2021 |
Jul 13, 2021 |
1 AOP
|
| 1323 |
1257: Induced parturition |
1141: Decreased, Reproductive Success |
Jan 13, 2017 |
Jan 13, 2017 |
1 AOP
|
| 1326 |
1257: Induced parturition |
1163: Increased, Reproductive Success |
Jan 13, 2017 |
Jan 13, 2017 |
1 AOP
|
| 1324 |
1255: induced spawning |
1141: Decreased, Reproductive Success |
Jan 13, 2017 |
Jan 13, 2017 |
None
|
| 1325 |
1255: induced spawning |
1163: Increased, Reproductive Success |
Jan 13, 2017 |
Jan 13, 2017 |
1 AOP
|
| 2295 |
1741: Induced, Angiotensin (Ang) II accumulation |
1849: Impaired gustatory nerve |
Mar 28, 2021 |
Mar 28, 2021 |
None
|
| 2322 |
1741: Induced, Angiotensin (Ang) II accumulation |
1852: Increased Ang II type 1 receptor (AT1R) |
Apr 10, 2021 |
Apr 10, 2021 |
None
|
| 2520 |
1741: Induced, Angiotensin (Ang) II accumulation |
1853: Hyperactivation of ACE/Ang-II/AT1R axis |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 1961 |
1666: dysfunction of microcirculation |
1667: anterior-posterior axis development |
Jul 3, 2019 |
Jul 3, 2019 |
1 AOP
|
| 2512 |
1666: dysfunction of microcirculation |
1750: Increased inflammatory immune responses |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 1221 |
1167: induced, parturition |
1141: Decreased, Reproductive Success |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 2021 |
1711: Induction of GATA3 expression |
1712: Increase of Th2 cells producing IL-4 |
Dec 29, 2019 |
Aug 14, 2020 |
1 AOP
|
| 2538 |
1959: Induction of hERG trafficking defects |
1960: Inhibition of Ikr |
Dec 13, 2021 |
Dec 13, 2021 |
None
|
| 1630 |
1459: Cell damage sensing |
1455: Sustained inflammatory cytokine release |
Jul 26, 2017 |
Jul 26, 2017 |
None
|
| 1632 |
1459: Cell damage sensing |
1032: Increased, secretion of local growth factors |
Jul 26, 2017 |
Jul 26, 2017 |
None
|